Trump Executive Order Tracker | Akin Public Policy and Lobbying

Protecting Children from Chemical and Surgical Mutilation (Trump EO Tracker)

January 24, 2025

Reading Time : 2 min
Trump Executive Order Tracker | Akin Public Policy and Lobbying

Key Updates

Summary

The Executive Order announces that the United States "will not fund, sponsor, promote, assist, or support the so-called ‘transition’ of a child from one sex to another and will rigorously enforce all laws that prohibit or limit these procedures. The order directs all agencies to rescind and amend all policies that rely on guidance from the World Professional Association for Transgender Health (WPATH). The order makes additional directives to the heads of executive departments and agencies, such as the Secretary of HHS, to take immediate actions to prevent the “chemical and surgical mutilation of children.” The order also directs the Director of the Office of Personnel Management to include provisions in the Federal Employee Health Benefits and Postal Service Health Benefits programs excluding coverage for pediatric transgender surgeries or hormone treatments.

Deadline as stated in original EO: Within 90 days, the Secretary of HHS shall publish a review of existing literature on best practices for promoting the health of children with gender dysphoria “or other identity-based confusion.” Within 60 days, the heads of agencies identified in the EO shall submit a single report to the Assistant to the President for Domestic Policy detailing implementation progress and a timeline for future action. 

Legal Challenges

Case Name PLGAG Inc. et al. v. Donald J. Trump et al., Case No. 1:25-cv-00337
Date Complaint Filed February 4, 2025 (amended complaint)
Venue

United States District Court for the District of Maryland

Summary

Plaintiffs are seeking to enjoin Defendants (President Trump and various agencies and officials) from implementing or enforcing Section 3(g) of E.O. 14168 and E.O. 14187 and declare these provisions unconstitutional and unlawful. They argue that these executive orders are in excess of presidential authority, conflict with existing statutes, violate the Equal Protection Clause of the Fifth Amendment, violate Substantive Due Process under the Fifth Amendment, and violate the Plaintiff’s freedom of speech under the First Amendment.

Related Cases

Additional Documentation

Share This Insight

Related Content

Trump Executive Order Tracker

The significant number of executive orders published by the Trump Administration cut across dozens of industries and areas of law. This searchable tool breaks down the orders and their impacts on specific industries and with in-depth analysis of specific orders.

Previous Entries

Trump Executive Order Tracker

May 29, 2026

The Executive Order (“EO”) directs the alignment of the U.S. core childhood vaccine schedule with the best practices of peer, developed countries, while preserving access to vaccines and protecting religious freedoms and enforcing legal protections for parents. Based on a scientific assessment completed by HHS pursuant to a Presidential Memorandum dated December 5, 2025, the order notes that the U.S. currently recommends more childhood vaccines than any peer nation and identified a set of consensus vaccines consistently recommended across all peer countries. The order directs the Centers for Disease Control and Prevention (“CDC”) and its Advisory Committee on Immunization Practices (ACIP) to review the scientific assessment and take appropriate steps to update the childhood and adolescent vaccine schedule, while providing maximum flexibility to parents and doctors regarding the timing and sequencing of routine immunizations. Additionally, all immunizations on the ACIP-recommended schedule and adopted by the CDC must continue to be covered without cost sharing by private insurance, Medicaid, the Children’s Health Insurance Program, and the Vaccines for Children Program. The order also reaffirms the Administration’s commitment to fulfilling all legal obligations with respect to parental authority, religious freedom, disability accommodations, and equal protection under the law.

...

Read More

Trump Executive Order Tracker

May 1, 2026

Expands upon Executive Order 14380 that established a national emergency regarding Cuba due its threat to U.S. national security by directing the Department of State and Treasury to block U.S. trade with foreign persons designated for operating in specified sectors of the Cuban economy, imposing immigration penalties and suspending entry for designated individuals associated with the Cuban government as determined by the Department of State, and directing the Treasury Department to sanction foreign financial institutions.

...

Read More

Trump Executive Order Tracker

April 30,2026

Grants Bridger Pipeline Expansion LLC a Presidential permit to construct and operate a cross-border oil pipeline in Montana, subject to federal oversight, compliance with all applicable laws, and conditions on modification, inspection, reporting, and potential government control or removal.

...

Read More

Trump Executive Order Tracker

April 30, 2026

Establishes a policy shift in federal procurement to prioritize fixed-price, performance-based contracts over cost-reimbursement models, aiming to improve cost predictability, strengthen contractor accountability, and reduce government overspending. Requires justification and senior-level approval for non-fixed-price contracts above certain thresholds and directs agencies to review and potentially renegotiate existing high-value contracts to incorporate performance-based pricing.
 
Within 45 days, the Office of Management and Budget must issue implementation guidance. Within 90 days, agencies must review and begin modifying their largest contracts and submit initial reports. Within 120 days, proposed updates to the Federal Acquisition Regulation and training programs must be developed.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.